During the Trading Day
| 4.58 |  -0.19 / -3.98% |
Data as of 4:00pm ET | Day’s Change | |
| 4.61 |  +0.0288 / +0.63% |
| Volume: 200.00 |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $150.6M |
Company Description
BIOLASE, Inc. is a medical technology company that develops, manufactures, and markets lasers, and markets and distributes dental imaging equipment and other related products designed to improve technologies for applications and procedures in dentistry and medicine. The company offers two categories of laser system products: Waterlase systems and Diode systems. Its flagship product category, the Waterlase system, uses a patented combination of water and laser to perform most procedures, performs using dental drills, scalpels and other traditional dental instruments for cutting soft and hard tissue. It also offers a family of Diode laser system products, including its ezlase soft tissue diode laser, to perform soft tissue and cosmetic procedures, including tooth whitening. The company also manufactures and sells accessories and disposables for its laser systems, such as hand pieces, laser tips and tooth whitening gel. BIOLASE was founded in 1987 and is headquartered in Irvine, CA.
Employees
Shareholders
| Individual stakeholders | 9.86% |
| Mutual fund holders | 6.10% |
| Other institutional | 28.17% |
Top Executives
| Federico Pignatelli | Chairman & Chief Executive Officer |
| Frederick D. Furry, MBA, CPA | Chief Operating & Financial Officer |
| Dmitri Boutoussov, PhD | Chief Technology Officer & VP-Engineering |
| Samir Chowdhury, PhD | General Manager |
| Sam Son | Vice President-Asia Pacific Operations |
.
